CompaniesCenetron Diagnostics

Cenetron Diagnostics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

126

By Phase

NA: 1

By Status

UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT01568138
Hover over trial bars to see details

Recent Trials

NCT04613323Lead Sponsor
Management of Thyroid Function in Hashimoto's Thyroiditis During Pregnancy
N/AUnknown
100 participants
Started: Jan 1, 2022 · Completed: Sep 1, 2022
NCT01568138Collaborator
Prospective Study of the BioVentrix PliCath HF™ System for the Treatment of Ischemic Cardiomyopathy
NACompleted
26 participants
Started: Aug 31, 2010 · Completed: Aug 31, 2015
Related Companies
Versiti Blood Center
acquired